EMEA-000128-PIP01-07-M08 - paediatric investigation plan

liraglutide

Key facts

• Invented name:
  • Victoza
  • Victoza
• Active Substance:
  liraglutide
• Therapeutic area:
  Endocrinology-Gynaecology-Fertility-Metabolism
• Decision number:
  P/0218/2017
• PIP number:
  EMEA-000128-PIP01-07-M08
• Pharmaceutical form(s):
  Solution for injection in pre-filled pen
• Condition(s) / indication(s):
  Treatment of type II diabetes mellitus
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  09/08/2017

Decision

P/0218/2017: EMA decision of 9 August 2017 on the acceptance of a modification of an agreed paediatric investigation plan for liraglutide (Victoza), (EMEA-000128-PIP01-07-M08)

AdoptedReference Number: EMA/459439/2017